These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7020533)
1. Opiates, opioid peptides and psychiatry. Davis GC; Buchsbaum MS; Bunney WE Ann N Y Acad Sci; 1981; 362():67-75. PubMed ID: 7020533 [No Abstract] [Full Text] [Related]
2. Endorphins in psychiatry: an overview and a hypothesis. Verebey K; Volavka J; Clouet D Arch Gen Psychiatry; 1978 Jul; 35(7):877-88. PubMed ID: 209757 [TBL] [Abstract][Full Text] [Related]
3. [Endorphins in psychiatry]. Lajeunesse C; Villeneuve A Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051 [No Abstract] [Full Text] [Related]
4. Psychopathology and endorphins. Davis GC; Bunney WE Adv Biochem Psychopharmacol; 1980; 22():455-63. PubMed ID: 6994443 [TBL] [Abstract][Full Text] [Related]
5. Investigating opioid peptides in schizophrenia and depression. Berger PA; Watson SJ; Akil H; Barchas JD Res Publ Assoc Res Nerv Ment Dis; 1986; 64():309-33. PubMed ID: 2941840 [No Abstract] [Full Text] [Related]
6. Opioid agonists and antagonists in schizophrenia. Barchas JD; Berger PA; Watson SJ; Akil H; Li CH Adv Biochem Psychopharmacol; 1980; 22():447-53. PubMed ID: 7395601 [No Abstract] [Full Text] [Related]
7. The measurement of endorphins in body fluids. Naber D; Pickar D Psychiatr Clin North Am; 1983 Sep; 6(3):443-56. PubMed ID: 6359091 [TBL] [Abstract][Full Text] [Related]
10. Putative neuroprotective agents in neuropsychiatric disorders. Dodd S; Maes M; Anderson G; Dean OM; Moylan S; Berk M Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():135-45. PubMed ID: 23178231 [TBL] [Abstract][Full Text] [Related]
11. Medical research council unit for metabolic studies in psychiatry, Sheffield. Jenner FA Psychol Med; 1973 Aug; 3(3):379-84. PubMed ID: 4729197 [No Abstract] [Full Text] [Related]
12. [The significance of endorphins and gamma-aminobutyric acid in clinical psychopharmacology (author's transl)]. Vinar O Cesk Psychiatr; 1978 Apr; 74(2):98-107. PubMed ID: 357024 [No Abstract] [Full Text] [Related]
13. Endogenous opiates and their actions. Lancet; 1982 Aug; 2(8293):305-7. PubMed ID: 6124720 [No Abstract] [Full Text] [Related]
14. [Endorphins. Physiological and pharmacological aspects, and research in psychiatry]. Leboyer M Encephale; 1986; 12(2):45-62. PubMed ID: 3527685 [TBL] [Abstract][Full Text] [Related]
15. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
16. Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential. Borgland SL; Labouèbe G Neuropsychopharmacology; 2010 Jan; 35(1):353-4. PubMed ID: 20010719 [No Abstract] [Full Text] [Related]
17. Clinical pharmacology of beta-endorphin in depression and schizophrenia. Catlin DH; Gorelick DA; Gerner RH Ann N Y Acad Sci; 1982; 398():434-47. PubMed ID: 6297363 [No Abstract] [Full Text] [Related]
18. Behavioral pharmacology of the endorphins. Berger PA; Akil H; Watson SJ; Barchas JD Annu Rev Med; 1982; 33():397-415. PubMed ID: 6282180 [No Abstract] [Full Text] [Related]